166 related articles for article (PubMed ID: 25799278)
1. Lewisy promotes migration of oral cancer cells by glycosylation of epidermal growth factor receptor.
Lin WL; Lin YS; Shi GY; Chang CF; Wu HL
PLoS One; 2015; 10(3):e0120162. PubMed ID: 25799278
[TBL] [Abstract][Full Text] [Related]
2. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC
Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885
[TBL] [Abstract][Full Text] [Related]
3. Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways.
Zhen L; Fan D; Yi X; Cao X; Chen D; Wang L
Int J Clin Exp Pathol; 2014; 7(10):6438-46. PubMed ID: 25400722
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcylation in oral squamous cell carcinoma.
Kongkaew T; Aung WPP; Supanchart C; Makeudom A; Langsa-Ard S; Sastraruji T; Chaiyarit P; Krisanaprakornkit S
J Oral Pathol Med; 2018 Mar; 47(3):260-267. PubMed ID: 29327476
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells.
Iwase M; Takaoka S; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M
Oral Oncol; 2008 Apr; 44(4):361-8. PubMed ID: 17689285
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation.
Chiang WF; Cheng TM; Chang CC; Pan SH; Changou CA; Chang TH; Lee KH; Wu SY; Chen YF; Chuang KH; Shieh DB; Chen YL; Tu CC; Tsui WL; Wu MH
Oncogene; 2018 Jan; 37(1):116-127. PubMed ID: 28892050
[TBL] [Abstract][Full Text] [Related]
8. Effects of activated fibroblasts on phenotype modulation, EGFR signalling and cell cycle regulation in OSCC cells.
Berndt A; Büttner R; Gühne S; Gleinig A; Richter P; Chen Y; Franz M; Liebmann C
Exp Cell Res; 2014 Apr; 322(2):402-14. PubMed ID: 24394543
[TBL] [Abstract][Full Text] [Related]
9. Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.
Chen R; Jin G; Li W; McIntyre TM
J Immunol; 2018 Oct; 201(7):2154-2164. PubMed ID: 30150285
[TBL] [Abstract][Full Text] [Related]
10. Suppression of FUT1/FUT4 expression by siRNA inhibits tumor growth.
Zhang Z; Sun P; Liu J; Fu L; Yan J; Liu Y; Yu L; Wang X; Yan Q
Biochim Biophys Acta; 2008 Feb; 1783(2):287-96. PubMed ID: 18023290
[TBL] [Abstract][Full Text] [Related]
11. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
Xu KP; Yu FS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286
[TBL] [Abstract][Full Text] [Related]
12. Lupeol evokes anticancer effects in oral squamous cell carcinoma by inhibiting oncogenic EGFR pathway.
Rauth S; Ray S; Bhattacharyya S; Mehrotra DG; Alam N; Mondal G; Nath P; Roy A; Biswas J; Murmu N
Mol Cell Biochem; 2016 Jun; 417(1-2):97-110. PubMed ID: 27206736
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through the activation of the EGFR/AKT pathway.
Ohnishi Y; Yasui H; Kakudo K; Nozaki M
Int J Oncol; 2015 Dec; 47(6):2165-72. PubMed ID: 26497980
[TBL] [Abstract][Full Text] [Related]
15. SRC-family tyrosine kinases in wound- and ligand-induced epidermal growth factor receptor activation in human corneal epithelial cells.
Xu KP; Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2832-9. PubMed ID: 16799022
[TBL] [Abstract][Full Text] [Related]
16. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
[TBL] [Abstract][Full Text] [Related]
17. Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI-3 kinase/Akt.
Brusevold IJ; Aasrum M; Bryne M; Christoffersen T
J Oral Pathol Med; 2012 Aug; 41(7):547-58. PubMed ID: 22413835
[TBL] [Abstract][Full Text] [Related]
18. PTHrP promotes malignancy of human oral cancer cell downstream of the EGFR signaling.
Yamada T; Tsuda M; Ohba Y; Kawaguchi H; Totsuka Y; Shindoh M
Biochem Biophys Res Commun; 2008 Apr; 368(3):575-81. PubMed ID: 18261460
[TBL] [Abstract][Full Text] [Related]
19. Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling.
Chen HJ; Lin CM; Lee CY; Shih NC; Amagaya S; Lin YC; Yang JS
Int J Oncol; 2013 Aug; 43(2):629-37. PubMed ID: 23754208
[TBL] [Abstract][Full Text] [Related]
20. Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium.
Diamond ME; Sun L; Ottaviano AJ; Joseph MJ; Munshi HG
J Cell Sci; 2008 Jul; 121(Pt 13):2197-207. PubMed ID: 18544635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
